Nindl BC, Alemany JA, Tuckow AP, Rarick KR, Staab JS, Kraemer WJ, Maresh CM, Spiering BA, Hatfield DL, Flyvbjerg A, Frystyk J. Circulating bioactive and immunoreactive IGF-I remain stable in women, despite physical fitness improvements after 8 weeks of resistance, aerobic, and combined exercise training.
INSULIN-LIKE GROWTH factor-I (IGF-I) is an important anabolic and metabolic hormone that is thought to mediate many of the beneficial outcomes of physical activity (1, 9, 31) . IGF-I is a ubiquitous hormone that can act in both systemic and local modes of action (1, 36) . Local (i.e., muscle) IGF-I has been consistently demonstrated to be increased after both acute and chronic exercise, whereas results for circulating IGF-I have been more equivocal (increases, decreases, and no changes have been reported) (1, 8, 10, 18, 27, 29, 30, 35, 37, 39, 40) . These disparate findings for circulating vs. local IGF-I have yet to be fully understood and have led some to question the physiological significance of circulating IGF-I with regard to training-induced adaptations. It is important to point out, however, that a wealth of scientific data from basic, applied, clinical, and epidemiological approaches have been accumulating, suggesting that the utility of circulating IGF-I may reside in the potential for measured concentrations to provide insight with regard to fitness, health, training, metabolic, and disease status (31) . For example, elevated IGF-I concentrations have been positively associated with aerobic fitness (8) , muscle volume (10), bone and tendon health (17, 32, 34) , cognitive function (31) , and decreased mortality (4). Conversely, not all studies have shown positive associations, and, in fact, elevated IGF-I has also been reported to be a cancer risk factor (31) . It is clear that the precise and relative role of systemic vs. locally produced IGF-I in mediating the outcomes of different physical activity modalities are far from fully understood.
Adding further ambiguity to the role that IGF-I plays in mediating chronic exercise-induced training adaptations and counterintuitive to IGF-I's anabolic role, a number of studies have actually reported that circulating IGF-I declines during longitudinal exercise training, despite positive neuromuscular and body composition changes (8, 10, 11, 29, 39) . Decreased IGF-I concentrations have been observed after training for adolescent boys and girls who experience increased thigh muscle volume (8, 10) , end-stage renal disease patients who experience improved strength (29) , and soldiers who experience improved aerobic fitness (39) . Furthermore, in a recent study from our laboratory, where diet, sleep, and physical activity levels were strictly controlled, circulating IGF-I declined 30% during an increase in physical activity over a 7-day period, regardless of whether subjects were in an energy deficit (1,000 kcal/day) or in energy balance. This finding leads us to conclude that unexplained, exercise-associated mechanisms, such as increased energy flux, are associated with declines in circulating IGF-I concentrations (38) .
In an attempt to reconcile this seemingly paradoxical phenomena, Eliakim et al. have postulated that circulating IGF-I exhibits a biphasic response pattern, whereby IGF-I declines during the initial stages of increased physical activity, dependent on the nutritional and metabolic demands placed on individuals, and, after a chronic adjustment, circulating IGF-I increases (9) . This is an intriguing hypothesis that is partially supported by short-term studies reporting decreases and longer term studies reporting increases (8, 10, 29, 39, 40) . However, few studies have actually been able to capture this potential biphasic IGF-I response pattern during physical training programs. Additionally, most studies to date have only examined singular physical training programs, with no studies available in the literature comparing diverse training programs (i.e., resistance, aerobic, and combined physical training) involving contrasting metabolic demands, muscle fiber recruitment and contractile patterns, and phenotypic outcomes.
Another important aspect of IGF-I biology that has largely been unexplored with regard to longitudinal exercise training is the measurement of IGF-I bioavailability and bioactivity. A family of at least six different binding proteins, as well as various proteases in the systemic circulation, can modify the extent to which IGF-I can interact with cellular IGF-I receptors and exert a biological outcome (7, 11, 12) . Traditional immunoassays only provide immunoreactive IGF-I concentrations, which are difficult to interpret with respect to bioactivity, due to the complex interactions of IGF-I with the binding proteins (which can inhibit or stimulate IGF-I-mediated effects). Chen et al. (7) have developed a highly sensitive and IGF-I-specific kinase receptor activation assay (KIRA), which determines the ability of circulating IGF-I to activate the IGF-I receptor by quantification of intracellular receptor autophosphorylation on IGF-I binding. This IGF-I bioassay represents an important tool that can broaden our understanding of the IGF-I system in health and disease. For example, circulating bioactive IGF-I has been shown to be more sensitive than total IGF-I relative to fasting declines (42) and with regard to decreased mortality and cardiovascular disease risk (4) . Using an acute exercise model, Kanaley et al. (18) have reported the only data on IGF-I bioactivity in which no changes were observed after 45 min of cycle ergometry exercise. The potential for longitudinal exercise training to alter bioactive IGF-I has not been addressed. We reasoned that an assessment of bioactive IGF-I during chronic exercise training might reveal a response pattern of greater physiological relevance than traditional measurement of immunoreactive IGF-I and could provide new insight with regard to IGF-I biology and exercise.
Therefore, the purpose of the present study was twofold: 1) to determine the extent to which an IGF-I bisphasic response pattern could be observed in three 8-wk exercise training programs consisting of different metabolic and neuromuscular demands [resistance, aerobic, and resistance ϩ aerobic (combined exercise)], and 2) comprehensively assess aspects of the circulating IGF-I system: total immunoreactive IGF-I, free immunoreactive IGF-I, bioactive IGF-I, IGF-binding proteins (IGFBP)-1, -2, and -3, and the proportion of IGFBP-1 complexed to IGF-I. We hypothesized that a physical training program involving a greater exercise volume and metabolic demand (i.e., combined exercise training) would result in greater perturbations in the IGF-I system compared with singular modes of exercise training (resistance or aerobic), and that IGF-I bioactivity would prove to be superior than immunoreactive IGF-I in reflecting training-associated fitness improvements.
METHODS

Experimental Design
This study was a prospective, between-group design utilizing a control (C) group and matched subject cohorts to reduce experimental variance. Before experimental treatments, 58 women were matched for age, body mass, height, strength, and peak O 2 consumption (V O2peak) and randomly assigned to a C group, a resistance exerciseonly (R) group, an aerobic endurance exercise-only (E) group, or a combined resistance and aerobic exercise (CB) group. Each of the three treatment groups (E, R, and CB) trained 3 days/wk for 8 wk, with testing conducted at pre-(Pre), mid-(Mid), and posttraining (Post). These groups allowed for direct comparison of the influence of each training modality on measured components of the circulating IGF-I system. Each subject was directly supervised by a certified strength and conditioning specialist to ensure program compliance. The data presented herein were part of a larger study examining the effects of training on bone biomarkers (23) .
Subjects
Fifty-eight women from the ages of 18 to 26 yr were recruited from a state university community and completed the study. There were no significant differences between the experimental groups for descriptive characteristics at baseline (20.2 Ϯ 2.1 yr, 165.3 Ϯ 6.3 cm, 64.2 Ϯ 9.1 kg). Each subject was briefed concerning all potential risks of the experimental protocol, and voluntarily signed an informed consent document approved by the Institutional Review Boards of the US Army Research Institute of Environmental Medicine and the University of Connecticut before participation in the investigation. The study was approved by both the US Army Research Institute of Environmental Medicine and the University of Connecticut Human Use and Review boards.
All subjects were required to meet a strict set of inclusion criteria: regularly menstruating, not pregnant, not currently lactating, not participating in any structured physical training program more than two times per week for the preceding 6 mo, and willing to participate in a experimental physical training study requiring a 12-wk commitment. Additionally, all subjects were required to undergo a comprehensive physical exam by a physician to identify and eliminate confounding endocrine, orthopedic, or other adverse pathologies that would endanger the volunteers or impact their response to training. Due to potential influences of estrogen levels on IGF-I concentrations, all women were tested in approximately the same phase of their menstrual cycles, with blood draws scheduled according to the women's self-reports of their menstrual status.
Training Groups E training group (n ϭ 13). An outline of the endurance training program is listed in Table 1 . Subjects in the E and CB groups performed running-based endurance exercise sessions on 3 alternating days/wk. Endurance sessions were periodized between continuous running and sprint-type interval training on different days. All sessions began with a 5-to 10-min warmup that included light jogging and dynamic range of motion exercises before training and ended with a 5-to 10-min cool down. The weekly training was composed of 20 -30 min of continuous running at a prescribed target heart rate of 70 -85% maximum heart rate, or interval running consisting of 400-, 800-, 1,200-, and 1,600-m runs conducted close to maximal intensity with a 1:1 recovery time. This program was designed specifically to improve 3.2-km run time.
R training group (n ϭ 18). Subjects in the R and CB groups trained on 3 alternating days, and each session lasted ϳ60 min. A nonlinear periodized model was used in which loads and repetitions were varied on a daily basis over each week. Table 2 contains an outline of the resistance training program. Following a 2-wk pretesting and familiarization period, the initial training (weeks 3-5) consisted of "light" days using 12-repetition maximum (RM) loads, "moderate" days using 8-to 10-RM loads, and "heavy" days using 6-to 8-RM loads. During weeks 6 -12, "light" days utilized 12-RM loads, "moderate" days utilized 6-to 8-RM loads, and "heavy" days utilized 3-to 5-RM loads.
CB training group (n ϭ 15). Subjects in the CB group performed both the aerobic and the resistance exercise programs on the same day, during the same session, and exercised 3 alternating days/wk utilizing the same periodization plan used by the R and E groups. Lightresistance training days always corresponded to the interval sprint days to not limit the intensity of the resistance training session. Resistance training sessions were performed first and were immediately followed by the aerobic training session. The CB group performed resistance training first so that lower body resistance exercises were performed in a nonfatigued state to ensure high-quality loading conditions. Individuals in the CB group strictly performed the same prescribed workouts as subjects in the E and R groups (i.e., they still performed the prescribed warmup exercises for the endurance training session, despite having just completed the resistance training session).
In addition, subjects in this group trained at the same time as the respective R and E groups to ensure that they received the same encouragement and coaching.
C group (n ϭ 10). This group did not undergo any formalized physical training. They completed all testing that the experimental groups performed, while maintaining their current activity levels.
Strength Assessments
1 RMs were tested on the squat and bench-press exercises on a MaxRack (Max Rack, Columbus, OH) using previously described methods (23) . Warm up consisted of performing 5-10 repetitions at 40 -60% perceived maximum, a 3-to 5-min rest and dynamic stretching period, and the completion of three to five repetitions at 60 -80% maximum. Three to five subsequent lifts were then made to determine the 1 RM, with a 5-min rest interval between lifts.
V O2peak
Subjects completed a 4-min warmup period at 8 km/h. If the subject's heart rate was Ͻ140 beats/min following 3 min of running, treadmill speed was increased to 8.9 or 9.7 km/h to elicit a heart rate Wednesday: leg press*, stiff-leg deadlift, incline bench press, seated row, shoulder press*, calf exercises, abdominal work
Friday: squat, stiff-leg deadlift, bench, lat pull down, upright row*, calf exercises, abdominal work n, Number; reps, repetitions; lat, lateral. *During week 6, the following exercises were changed: leg press to deadlift; upright row to high pull; shoulder press to push press. Ͼ150 beats/min. Following the warm-up period, treadmill grade was increased to 5% and was increased an additional 2.5% every 2 min. Expired air was measured continuously for oxygen and carbon dioxide concentrations using a calibrated metabolic measurement system (ParvoMedics, Salt Lake City, UT). Measurements were averaged over 20-s periods. The criteria for V O2peak was an increase of Ͻ2.0 ml·kg Ϫ1 ·min Ϫ1 in oxygen uptake with an increase in workload and respiratory exchange ratio Ն1.10, or when the subject could no longer maintain the pace.
Dual-energy X-ray Absorptiometry
Body composition was assessed by whole body scans using a fan-beam densitometer (Prodigy, GE Medical Systems, USA). Total body estimates of percent fat and nonbone fat-free mass were determined using manufacturer-described procedures and supplied algorithms (Total Body Analysis, version 3.6, Lunar, Madison, WI). The coefficient of variation (CV) has been reported to be 1% for fat-free mass and 2% for fat mass with this method (23) .
Dietary Intake
Food frequency, nutrition, and weight history questionnaires were administered during the pre-and posttesting phases to measure dietary change. Five-day food records were also collected on each subject to monitor dietary intake at baseline (week 0), Mid (week 4), and Post (week 9). During baseline screening, all subjects were instructed by registered dieticians on the proper method of recording food intake (19) . These educational sessions included examples and illustrations of how to quantify food intake. Food diaries were analyzed for energy and macro/micronutrient content (NUTRITIONIST PRO, version 1.1, First Databank, The Hearst, San Bruno, CA). Body weight was monitored weekly.
IGF-I System Assays
Blood was drawn via venipuncture at baseline, Mid, and Post. Participants were returned their dietary intake records Mid and Post so that they could eat the same food on the day before each resting blood draw. All blood draws were obtained after a minimum 12-h fast and in the approximate same phase of the menstrual cycle and with at least 48 h after their last exercise session to mitigate any effects from the last bout of exercise. Blood was allowed to sit for 30 min at room temperature and immediately centrifuged at 4°C at 2,000 g for 15 min. Serum samples were then separated and stored at Ϫ80°C until analysis. Total IGF-I concentrations were measured by an in-house noncompetitive, timeresolved immunofluorometric assay (TR-IFMA) after acid-ethanol extraction of serum with mean intra-and interassay CVs of Ͻ5 and 10%, respectively (13) . Free IGF-I concentrations were determined by an ultrafiltration method, as described by Frystyk et al. (15, 16) . Briefly, centrifugation of the serum sample is utilized in coordination with a semipermeable membrane, which allows only free IGF-I to pass through, leaving any IGF-I bound to a binding protein behind. After this ultrafiltration process, the ultrafiltrate was analyzed for IGF-I immunoreactivity with a sensitivity of 0.020 g/l and a mean intra-and interassay CVs of 15 and 20%, respectively. Bioactive IGF-I was measured by an IGF-I KIRA based on human embryonic renal cells (EBNA 293) transfected with the human IGF-I receptor (IGF-IR) gene. In this assay, cultured cells were stimulated with either IGF-I standards or unknown serum samples. After 15 min, samples were removed, and the cells were lysed. Then the crude cell lysates were transferred to an assay that detected the concentration of phosphorylated (i.e., activated) IGF-IRs. This assay used a monoclonal antibody against the extracellular IGF-IR for coating and a Europium-labeled monoclonal anti-phosphotyrosine antibody (PY20) as tracer. The sensitivity of the KIRA assay was Ͻ0.08 g/l. IGF-II cross-reacts by 12%, and proinsulin, insulin, and insulin analogs by Ͻ1% compared with IGF-I. The intra-and interassay CVs were Ͻ7 and 15%, respectively. IGFBP-1 was assessed by an in-house RIA, and IGFBP-2 by an in-house TR-IFMA (20) . Mean intra-and interassay variances were Ͻ6 and 12%, respectively. IGFBP-3 was analyzed by a commercial immunoradiometric assay from Diagnostic Systems Laboratories (Webster, TX). IGFBP-1 associated with IGF-I (binary complex of IGF-I and IGFBP-1) was determined by an in-house TR-IFMA using an IGFBP-1 antibody for coating, and a Europium-labeled IGF-I antibody as tracer (14) . Mean intra-and interassay variance was 5 and 15%, respectively.
Statistics
All data are presented as means Ϯ SE. Appropriate statistical assumptions for each analysis were tested before evaluation of the data. Descriptive and parametric statistical analyses were performed with STATISITCA 7 for Windows (StatSoft Tulsa, OK). A four (C, R, E, CB) by three (Pre, Mid, Post) analysis of variance (ANOVA) with repeated measures was employed for statistical analyses. When a significant F-ratio was identified, post hoc comparisons were conducted using Tukey's honestly significant difference test. Significance in this investigation was set at P Յ 0.05 for all measurements. 
RESULTS
Physical Performance
All physical performance measurement outcomes are presented in Table 3 . A group ϫ time interaction occurred for the 1-RM bench press (P ϭ 0.001). Both the R and CB groups experienced significant increases in 1-RM bench-press strength by the end of the study (as compared with their initial values) of 6.3 and 7.0 kg, respectively. There was a significant interaction of group ϫ time for the 1-RM squat (P ϭ 0.001). The results suggested that there was no increase in squat 1 RM in the C group, and that there was a progressive increase in squat 1 RM in E (ϩ7.6 kg), R (ϩ 26.8 kg), and CB (ϩ19.9 kg) exercise groups. There was no significant change in V O 2peak for the C or R exercise groups. However, a group ϫ time interaction (P ϭ 0.001) denoted that mean V O 2peak was significantly higher (compared with baseline) by 6% in the E exercise group and 8% in the CB exercise group.
Body Composition/Dietary Intake
Although there was no significant interaction of group ϫ time for body mass (P ϭ 0.5), there was a significant time effect (P Ͻ 0.004), indicating a significant increase (ϩ1 kg) Pre to Post (Pre: 61.6 Ϯ 1.1; Mid: 61.9 Ϯ 1.8; Post 62.6 Ϯ 1.3 kg). Fat-free mass had similar outcomes to body mass as no interaction occurred (P ϭ 0.8), but there was a significant time effect (P Ͻ 0.0001). Aggregated across all groups, fat-free mass was significantly increased (ϩ0. 
IGF-I System
Data for total, free, and bioactive IGF-I are presented in Table 4 . All groups had similar mean concentrations of total (264.4 Ϯ 16.7 g/l), free (0.7 Ϯ 0.1 g/l), and bioactive (2.4 Ϯ 0.6 g/l) IGF-I concentrations at the pretraining time point. There were no significant changes in total IGF-I concentrations over time (P ϭ 0.4), nor did total IGF-I concentrations vary among the groups over time (P ϭ 0.9). Similar statistical occurrences were evident for free and bioactive IGF-I, as concentrations did not vary over the training period, and no significant interactions occurred for free (P ϭ 0.7) or bioactive IGF-I (P ϭ 0.9). Total IGF-I significantly correlated with bioactive IGF-I at Pre (r ϭ 0.61, P Յ 0.05), Mid (r ϭ 0.49, P Յ 0.05), and Post (r ϭ 0.49; P Յ 0.05) time points. Also, free IGF-I significantly correlated with bioactive IGF-I at Pre (r ϭ 0.62, P Յ 0.05), Mid (r ϭ 0.52, P Յ 0.05), and Post (r ϭ 0.46, P Յ 0.05).
Data for the IGFBPs, binary IGFBP-1, and IGFBP-1 saturation are presented in Table 5 . There were no statistical differences at baseline among the four groups. There were no significant group ϫ time interactions for IGFBP-1 (P ϭ 0.5), IGFBP-2 (P ϭ 0.4), IGFBP-3 (P ϭ 0.9), binary IGFBP-1 (P ϭ 0.7), or IGFBP-1 saturation (P ϭ 0.4), in that concentrations of the aforementioned variables were consistent over the training period, among the groups. Similarly, IGFBP concentrations were stable over the training period, as no time effects were observed for mean IGFBP-1 (P ϭ 0.2), IGFBP-2 (P ϭ 0.8), and IGFBP-3 (P ϭ 0.8), binary IGFBP-1 (P ϭ 0.2), or IGFBP-1 saturation (P ϭ 0.5).
DISCUSSION
Whereas all previous circulating IGF-I/exercise training studies in the literature have focused on conventional immunoassays to measure total and free IGF-I, this is the first study that has assessed IGF-I bioactivity within a longitudinal exercise training paradigm by using a cell-based, in vitro IGF-I bioassay (KIRA) that quantifies phosphorylation of tyrosine residues of the activated IGF-I receptor (the requisite prelim- inary step in IGF-I-mediated intracellular signal transduction). The KIRA in vitro bioassay has the advantage over traditional immunoassays in that it considers important modifying elements (IGFBPs and proteases) known to influence the biological activity of IGF-I by quantifying a biological outcome (IGF-I receptor activation) rather than simply an immunological outcome (antibody specificity toward an epitope) (7, 11) . This study also measured total and free IGF-I, IGFBP-1, -2, and -3, and the proportion of IGFBP-1 complexed to IGF-I after three separate, 8-wk exercise training programs (resistance, aerobic, and combined exercise) performed on 3 alternating days/wk in young, healthy, previously untrained women. Overall, the training programs were effective in improving physical fitness specific to the exercise mode engaged in. Contrary to our study hypotheses that bioactive IGF-I would prove superior to immunoreactive IGF-I in reflecting training-associated fitness improvements and that the combined training would result in greater perturbations in the IGF-I system, our results indicate that the IGF-I system remained stable over the course of all three training programs. We conclude that increased lean mass (ϳ2%), aerobic fitness (6 -7%), and upper (20 -24%) and lower (15-48%) body strength resulting from an 8-wk exercise training programs can occur without concomitant increases in resting concentrations of either circulating bioactive or immunoreactive IGF-I, as well as associated IGFBPs. In terms of reflecting positive anabolic neuromuscular outcomes, these data support a growing consensus that locally produced IGF-I may be of greater relative importance than endocrine-derived IGF-I.
Our results differ from other short-term (ϳ1-11 wk) exercise training studies that have reported decreases in total IGF-I for such diverse populations as adolescent boys and girls, soldiers, and end-stage renal disease patients (8, 10, 29, 39) . Also, our study was not able to confirm Eliakim's theory of a biphasic (decrease and then increase) IGF-I response pattern during exercise training (9), at least not when comparing samples collected with 4-wk intervals. Based on the literature and two published studies from our laboratory (29, 38), we had anticipated observing a decrease in IGF-I at some point during the 8 wk of training. It is well known that IGF-I declines during a negative energy deficit, often coinciding with weight loss (25, 26, 28 33) . Furthermore, using regression analyses, Nemet et al. (25) have suggested that, even under conditions of energy balance, IGF-I declines following short-term physical training. In synthesizing the literature from available studies, Rarick et al. (38) recently postulated that IGF-I declines under highenergy flux conditions (high levels of both energy expenditure and energy intake under conditions of energy balance) by yet unexplained exercise-associated mechanisms. In providing a potential explanation for the lack of change in IGF-I for the present study, we propose that our young, healthy subjects were training under low-to-moderate energy flux conditions. The 3 alternating days/wk of the training programs were well tolerated by the subjects, as the training was progressive in nature, allowed for adequate recovery between sessions, ranged in total duration from 20 -90 min/session, and ranged in estimated caloric expenditure of 300 -600 kcal/session. As evidenced by body composition changes (significant 1.6 and Values are means Ϯ SE. IGFBP-1, -2, and -3, insulin-like growth factor binding proteins 1, 2, and 3, respectively. Binary IGFBP-1 represents the total amount of IGF-I that is complexed with IGFBP-1. IGFBP-1 saturation (%) represents the molar ratio of IGF-I to IGFBP-1. *Trend for a main between-group effect (P ϭ 0.07) for IGFBP-1 saturation.
1.9% increases for body mass and lean mass, respectively) and diet records (both caloric and macronutrient intake from selfreported diet records were similar throughout training), our subjects were in a slight positive energy balance. The weekly training volume in the present study was significantly less than those above-mentioned studies by Eliakim et al. (8, 10) and Rosendahl et al. (39) , in which training was conducted 5 days/wk, ranging from 90 to 240 min/workout, depending upon the study. Hence, other training studies of similar length to our study, which have reported a decline in IGF-I, have had total training durations/volumes 2-30 times higher than those of the present study. It is, therefore, suggested that exercise training volume, especially as it related to individual's fitness level, training background, and nutritional status, is an important determinant of the IGF-I response to chronic training. The underlying physiological mechanisms whereby exercise volume would exceed an individual's metabolic homeostatic capacity and perturb the IGF-I system remain unknown. Interestingly, Lavoie (21) has speculated that, during exercise, the energetic flux within the hepatocyte (changes in the ATP-to-P i ratio) may allow the liver to act as an afferent organ on the central nervous system, contributing to endocrine regulation. In support of this hypothesis, Lavoie et al. (22) have demonstrated that exercise-induced IGFBP-1 increases are linked to liver glycogen depletion. Future studies might be well served by considering that changes in the circulating IGF-I system during exercise offer greater insight into global metabolic demands, rather than local anabolic processes.
Studies reporting changes in IGF-I concentrations also typically demonstrate changes in IGFBPs. Variations in IGFBPs will influence the extent to which IGF-I is complexed among its free, binary, and ternary molecular isoforms, flux from the circulation to cellular receptors, and ultimately its bioactivity (11, 12, 30, 31) . The lack of changes in IGFBPs in this study is consistent with the lack of changes for bioactive IGF-I. One of the major advantages for the KIRA is that it considers the modifying actions of IGFBPs in the quantification of bioactive IGF-I. In validation of the assay, Chen et al. (7) reported that the addition of IGFBPs dose-dependently reduced the KIRA signal. During fasting, Chen et al. (6) have also reported that the significant elevations in IGFBP-1 and -2 correspond with bioactive IGF-I declines and precede immunoreactive IGF-I declines. Although IGFBP-1 was unchanged in this longitudinal training study, we have recently reported that IGFBP-1 was a sensitive biomarker for assessing the physiological strain of acute physical exercise, with increases perceptible for up to 24 h (27) . In the only other study to report KIRA assessed IGF-I bioactivity, but using acute exercise (45 min of cycle ergometry at the lactate threshold), Kanaley et al. (18) reported that significant increases in IGFBP-1 and -2 were associated with a trend (P ϭ 0.065) toward decreased IGF-I bioactivity. Other studies in the literature reporting acute exercise responses for immunoreactive IGF-I (2, 11, 18, 27, 30) have been equivocal with increases, decreases, and no changes being observed. While our present data do not support an argument for the use of bioactive IGF-I over immunoreactive IGF-I in providing additional insight into exercise-associated adaptations, other observations have suggested a utility for measures of bioavailable (i.e., free) and bioactive IGF-I. Measures of immunoreactive IGF-I in the present study only explained ϳ25% of the variance for measurement of bioactive IGF-I. These relationships are essentially the same as reported by Brugts et al. (5) in a study comparing IGF-I measures in a population of 426 healthy individuals (310 men and 116 women) aged 18 -79 yr. That study suggested that the IGF-I KIRA does, in fact, provide information on a different dimension about the IGF-I system. In another intriguing epidemiological report, Brugts et al. (4) observed that elevated IGF-I bioactivity in elderly men was associated with decreased mortality and reduced cardiovascular disease. In other studies involving situations (i.e., aging and military operational stress) where growth hormone secretion is known to be altered (decreases in aging and increases in acute military stress) (31, 33) , measures of immunoreactive free IGF-I have been associated with better cognitive function in older men and related to fat-free mass losses during military operational stress. Thus it appears the potential for measures of bioactive/free IGF-I to offer different information than provided for immunoreactive IGF-I occur during situations where there is either an alteration in GH secretion or dynamic changes in IGFBPs. The precise physiological importance of this information remains to be clarified.
While both circulating and local IGF-I clearly have anabolic actions, it is difficult to ignore the mounting experimental evidence marginalizing the importance of circulating IGF-I in mediating local muscle hypertrophy/remodeling. For example, the transgenic liver-IGF-I-deficient mouse, in which there is an 80% reduction in circulating IGF-I, have been shown to have normal body weight and growth phenotypes (43) . Recently, Matheny et al. (24) conducted a 16-wk training study in the liver-IGF-I-deficient mouse and reported a doubling in strength, muscle mass, IGF-I mRNA, and IGF-I receptor phosphorylation. Furthermore, Spangenburg et al. (41) have experimentally demonstrated that the IGF-I receptor is not even necessary for load-induced skeletal muscle hypertrophy. With regard to local mechanisms and the fact that exercise has been reported to increase IGF-I receptor phosphorylation (24) , it might be prudent to measure bioactive IGF-I in muscle interstitial fluid using microdialysis techniques (2, 3, 17) to determine the extent to which local anabolism might be reflected.
In summary, in young, healthy women who participated in either resistance, aerobic, or combined training on 3 alternating days/wk for 8 wk under low-to-moderate exercise volume/ energy flux conditions, we were able to demonstrate favorable body composition, strength, and aerobic fitness adaptations without changes in the circulating IGF system. Based on the present data and previous studies, we conclude that chronic exercise-induced changes in the circulating IGF system typically occur under conditions of increased exercise volume/ energy flux and are indicative of global metabolic demands, rather than local anabolic processes. of the Army endorsement or approval of the products or services of these organizations.
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